Cell Tissue Res 382(1):71
Wright commented that [t]he precise mechanism of these improvements remains speculative but does not appear to be purely related to weight loss. Indeed, he added, much of the benefit in these patients with heart failure seemed to be manifest prior to any substantial weight loss, strongly suggesting that the GLP-1 receptor agonist led to improvements in the metabolic syndrome and the heart failure syndrome, independent and perhaps additive to those expected from weight loss. Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, not involved in this research, welcomed its findings
Understanding GLP-3 or Triple-Agonist Medications What Is GLP-3
Important: The safety information summarized here reflects published clinical trial data and is presented for educational purposes only
The trial investigated Retatrutide as an agonist of the GIP, GLP-1 and glucagon receptors
As we age, NAD+ levels naturally decline, which can contribute to various health issues and the aging process itself.NAD+ IV therapy aims to replenish and maintain optimal levels of NAD+ in the body